12
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Placental growth hormone in Down's syndrome screening

, , &
Pages 241-243 | Published online: 07 Jul 2009

REFERENCES

  • Moghadam S, Engel W, Bougoussa M, et at. Maternal serum placental hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21. Fetal Diagn Ther 1998;13:291–7
  • Royston P, Thompson SG. Model-based screening by risk with application to Down's syndrome. Stat Med 1992;11:257–68
  • Cuckle HS. Improved parameters for risk estimation in Down's syndrome screening. Prenat Diagn 1995;15:1057–65

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.